Clinical Trials Browser

Phase 1/2 × Advanced Malignant Solid Tumors × 90 days × Clear all

NCT06499350 2026-03-10

A Study of FC084CSA in Combination of Tislelizumab in Patients With Advanced Malignant Solid Tumors

Phase 1/2 Recruiting

Other solid neoplasm

Advanced Malignant Solid Tumors